Interleukin-6 Receptor Antagonist [EPC]

98032 reported adverse events

Drugs of this class: SARILUMAB TOCILIZUMAB

These side effects are most commonly reported by patients taking drugs of the Interleukin-6 Receptor Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 32509
1 RHEUMATOID ARTHRITIS 19367
2 PAIN 17066
3 ARTHRALGIA 14341
4 OFF LABEL USE 14303
5 JOINT SWELLING 13015
6 FATIGUE 11786
7 DRUG INTOLERANCE 10649
8 RASH 10454
9 CONTRAINDICATED PRODUCT ADMINISTERED 9853
See all common reactions for Interleukin-6 Receptor Antagonist [EPC]

Drugs of the Interleukin-6 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 280 0.9272
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3487 0.9088
2 SWOLLEN JOINT COUNT INCREASED 932 0.8902
3 DISABILITY ASSESSMENT SCALE SCORE INCREASED 234 0.8764
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 179 0.8326
5 RHEUMATOID FACTOR POSITIVE 2856 0.8221
6 RED BLOOD CELL SEDIMENTATION RATE 208 0.8031
7 RHEUMATIC FEVER 1135 0.7920
8 LUPUS VULGARIS 137 0.7919
9 PEMPHIGUS 6260 0.7882
See all enriched reactions for Interleukin-6 Receptor Antagonist [EPC]